Companies: 10,795·Total market cap: $144.5T
Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc.

ORMPNASDAQHealthcare● Active
$3.64
$-0.07(-1.89%)
Market Cap$148970935
P/E Ratio
52W High$5.01
52W Low$1.98

Oramed Pharmaceuticals Inc.(ORMP)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ORMP · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-08
Revenue
Revenue$2.00M$0.00M$1.34M$2.70M$2.70M
Cost of Revenue$1.99M$0.19M$0.00M$0.00M$0.00M
Gross Profit$0.01M($0.19M)$1.34M$2.70M$2.70M
Gross Margin %(computed)0.65%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$6.38M$6.32M$8.97M$27.64M$20.99M
G&A Expenses$8.72M$6.46M$8.43M$13.81M$5.94M
Total Operating Expenses$15.10M$12.78M$17.11M$43.30M$26.93M
Operating Income($15.09M)($12.78M)($15.77M)($40.60M)($24.22M)
Operating Margin %(computed)-754.40%-896.15%
Interest Income$2.37M$0.00M$8.03M$3.57M$0.35M
Interest Expense$0.00M$0.85M$3.58M$0.00M$0.01M
Income Before Tax$75.32M($15.92M)$5.09M($37.66M)($22.99M)
Income Tax Expense$11.31M$3.18M$0.00M$0.10M($2.88M)
Net Income$64.05M($19.10M)$5.53M($37.76M)($22.24M)
Net Margin %(computed)412.31%-822.72%
Per Share & EBITDA
EPS (Basic)$1.53$-0.47$0.14$-0.97$-0.78
Wtd Avg Shares41.40M40.83M40.32M39.00M28.47M
EBITDA$75.44M($14.87M)$7.32M($36.98M)($25.04M)
EBITDA Margin %(computed)546.34%-926.34%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Oramed Pharmaceuticals Inc.

关于Oramed Pharmaceuticals Inc.(ORMP)损益表

Oramed Pharmaceuticals Inc.(ORMP)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ORMP实现营收$0.00B,毛利润$0.00B(毛利率0.65%),净利润$0.06B(净利率3202.50%)。

常见问题

ORMP · 4 问

Oramed Pharmaceuticals Inc.(ORMP)2025财年营收为$0.00B,同比up—%。

ORMP revenueORMP salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09